QUICK TAKE: SUN PHARMA GAINS ON SPECIALTY UPTICK

The stock of the country’s largest drug maker, Sun Pharmaceutical Industries is up 10 per cent over the last fortnight. Traction in its specialty portfolio in the US and higher growth trajectory in the domestic formulations business are expected to boost the revenue and profit growth going ahead